Learn More
Medchemexpress LLC 4H-1-Benzopyran-4-one, 6-methoxy-5-nitro-2-(trifluoromethyl)- | 342795-08-8 | 99.85% | 289.16 | 50 MG

Supplier: Medchemexpress LLC HY11155010MG
Bragsin2 is a potent, selective, and noncompetitive nucleotide exchange factor BRAG2 inhibitor with an IC50 of 3 μM. It binds at the interface between the PH domain of BRAG2 and the lipid bilayer, preventing activation of lipidated Arf GTPase. This compound affects breast cancer stem cells.
- Potent, selective, and noncompetitive nucleotide exchange factor BRAG2 inhibitor with an IC50 of 3 μM.
- Binds at the interface between the PH domain of BRAG2 and the lipid bilayer.
- Leads to BRAG2 being unable to activate lipidated Arf GTPase.
- Affects breast cancer stem cells.
- Inhibits Arf GTPase activation in HeLa cells at 50 μM.
- Inhibits the growth of SUM149 and S68 cells at 50 μM.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.